NCT06688409 Accuracy Testing of Validated and Non-validated Home BP Devices Sold on the Online Market.
| NCT ID | NCT06688409 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2024-02-12 |
| Primary Completion | 2027-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2024-02-12 with a primary completion date of 2027-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess whether validated and non-validated blood pressure measuring devices sold on the online market are accurate in regards to the mean awake BP from ambulatory blood pressure monitoring.
Eligibility Criteria
Inclusion Criteria: * Adults aged \> 18 years scheduled to undergo an ABPM Exclusion Criteria: * Upper arm size outside of cuff range of selected devices (\<22 cm or \>42 cm) * Night shift workers * Permanent atrial fibrillation * Known severe aortic stenosis * Contraindication to measure BP on the non-dominant arm * Ongoing pregnancy * Inability or unwillingness to provide consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06688409 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06688409 currently recruiting?
Yes, NCT06688409 is actively recruiting participants. Contact the research team at remi.goupil@umontreal.ca for enrollment information.
Where is the NCT06688409 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06688409 clinical trial?
NCT06688409 is sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal. The trial plans to enroll 140 participants.